Instil Bio
Latest round
- Series C
Last raised
- Dec 2020
Total raised
- $356M
Investors
- 1
About Instil Bio
Instil Bio, Inc.Founded in 2018 in Dallas, US, Instil Bio, Inc. is a clinical-stage biopharmaceutical company specializing in cancer therapies.Instil Bio is a clinical-stage biopharmaceutical company specializing in innovative therapies, particularly its lead asset, AXN-2510. This bispecific antibody targets both PD-L1 and VEGF, addressing critical needs in solid tumor cancer treatment.In 2020, Instil Bio generated revenue of USD 138,000, with an EBITDA of USD -73,541,000. The company is targeting new geographic markets in Asia for its therapies and aims to advance product development and launch timelines.
Who invested in Instil Bio
1 investor across 2 rounds
See all investors in Instil Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Instil Bio
Who invested in Instil Bio?
Instil Bio has 1 investor on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Instil Bio raised?
Instil Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Instil Bio last raise money?
Instil Bio's most recent round on record is a Series C, in Dec 2020.
What does Instil Bio do?
Instil Bio is a biotechnology company.
Where is Instil Bio headquartered?
Instil Bio is headquartered in Dallas, US.
Which VCs invest in companies like Instil Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Instil Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Instil Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.